Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
This study is ongoing, but not recruiting participants.
Study NCT00000393   Information provided by National Institute of Mental Health (NIMH)
First Received: January 17, 2000   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Cognition Disorders
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Immunologic Deficiency Syndromes
Infection
More general conditions related to this trial
Delirium, Dementia, Amnestic, Cognitive Disorders
Immune System Diseases
Lentivirus Infections
Mental Disorders
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Peptide T
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services